HER-2/Neu overexpression is a rare event in peri-ampullary cancer: assessment using the HercepTest.

Suppr

超能文献

作者信息

Aloysius Mark M, Lobo Dileep N, Rowlands Brian J, Madhusudan Sreenivasan, Ilyas Mohammad, Zaitoun Abed M

出版信息

Histopathology. 2009 Aug;55(2):236-7. doi: 10.1111/j.1365-2559.2009.03351.x.

DOI:10.1111/j.1365-2559.2009.03351.x

PMID:19694833

Abstract

摘要

相似文献

HER-2/Neu overexpression is a rare event in peri-ampullary cancer: assessment using the HercepTest.

Histopathology. 2009 Aug;55(2):236-7. doi: 10.1111/j.1365-2559.2009.03351.x.

Coexpression of EGFR and HER-2 in pancreatic ductal adenocarcinoma: a comparative study using immunohistochemistry correlated with gene amplification by fluorescencent in situ hybridization.

Oncol Rep. 2007 Jul;18(1):151-5.

Amplification and overexpression of HER-2/neu in invasive ductal carcinomas of the pancreas and pancreatic intraepithelial neoplasms and the relationship to the expression of p21(WAF1/CIP1).

Neoplasma. 2004;51(2):77-83.

Overexpression of the HER-2/neu oncogene in pancreatic adenocarcinoma.

Am J Clin Oncol. 2001 Oct;24(5):496-9. doi: 10.1097/00000421-200110000-00016.

HER-family gene amplification and expression in resected pancreatic cancer.

Eur J Surg Oncol. 2009 Oct;35(10):1098-104. doi: 10.1016/j.ejso.2009.02.013. Epub 2009 Mar 21.

Current status of gene expression profiling of pancreatic cancer.

Int J Surg. 2008 Feb;6(1):81-3. doi: 10.1016/j.ijsu.2006.09.001. Epub 2006 Oct 27.

Interobserver reproducibility of Her-2/neu protein overexpression in invasive breast carcinoma using the DAKO HercepTest.

Am J Clin Pathol. 2002 Nov;118(5):693-8. doi: 10.1309/6ANB-QXCF-EHKC-7UC7.

Detecting and diagnosing ampullary neoplasms.

Cancer Biol Ther. 2004 Jul;3(7):657-9. doi: 10.4161/cbt.3.7.1051. Epub 2004 Jul 20.

[Immunohistochemical study of mucins in chronic pancreatitis and ductal adenocarcinoma of the pancreas].

Arkh Patol. 2008 Jul-Aug;70(4):13-7.

Gene expression profiling identifies markers of ampullary adenocarcinoma.

Cancer Biol Ther. 2004 Jul;3(7):651-6. doi: 10.4161/cbt.3.7.919. Epub 2004 Jul 9.

引用本文的文献

Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients.

Cancers (Basel). 2020 Dec 7;12(12):3670. doi: 10.3390/cancers12123670.

Liquid biopsy and multi-analyte testing guided treatment of positive periampullary adenocarcinoma with durable complete response after trastuzumab based therapy.

Oncotarget. 2020 Nov 10;11(45):4195-4200. doi: 10.18632/oncotarget.27793.

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis.

BMC Cancer. 2019 Dec 5;19(1):1191. doi: 10.1186/s12885-019-6320-y.

The HER3 pathway as a potential target for inhibition in patients with biliary tract cancers.

PLoS One. 2018 Oct 18;13(10):e0206007. doi: 10.1371/journal.pone.0206007. eCollection 2018.

HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?

Cancer Metastasis Rev. 2017 Mar;36(1):141-157. doi: 10.1007/s10555-016-9645-x.

Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1, 2 and 3 in Periampullary Adenocarcinoma.

PLoS One. 2016 Apr 12;11(4):e0153533. doi: 10.1371/journal.pone.0153533. eCollection 2016.

Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2).

Mod Pathol. 2015 Aug;28(8):1123-9. doi: 10.1038/modpathol.2015.57. Epub 2015 May 15.

Predictive value of tumor proliferative indices in periampullary cancers: Ki-67, mitotic activity index (MI) and volume corrected mitotic index (M/V) using tissue microarrays.

World J Surg. 2010 Sep;34(9):2115-21. doi: 10.1007/s00268-010-0681-3.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验